The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.025
Bid: 0.024
Ask: 0.027
Change: 0.0005 (2.00%)
Spread: 0.003 (12.50%)
Open: 0.026
High: 0.03
Low: 0.025
Prev. Close: 0.025
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outcome of General Meeting

30 Dec 2021 13:51

RNS Number : 0913X
Supply @ME Capital PLC
30 December 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

30 December 2021

 

Supply@ME Capital plc

(The "Company", "the Group" or "SYME")

Outcome of General Meeting

A General Meeting of Supply@ME Capital plc, the innovative fintech platform (the "Platform"), which provides the Inventory Monetisation© service to manufacturing and trading companies, was duly convened earlier today (the "Meeting").

The Meeting was held to enable shareholders to consider whether any, and if so, what steps should be taken to address the Company's "serious loss of capital" as defined and required by section 656(1) of the Companies Act 2006. Details of the largely historical situation which resulted in this position were set out in the formal Notice of General Meeting and the Company's RNS of 7 December 2021.

Following discussions at today's Meeting, it was concluded that the Company's anticipated increase in revenues commencing in 2022 from each of the three revenue streams (per the definitions introduced in the RNS of 31 August 2021), which includes the positive impacts generated by the completion of the first inventory monetisation transactions and the acquisition of TradeFlow Capital Management Pte. Ltd, will contribute towards alleviating the loss of capital. The "serious loss of capital" does not itself have any specific bearing on the Company's current financial position or current trading performance.

The Company also intends to issue a trading update, covering the second half of 2021, tomorrow, 31 December 2021.

Shareholders were not asked to vote at the general meeting as it was a discussion forum only.

The board of SYME always welcomes dialogue with shareholders and today's General Meeting provided a suitable forum for discussions on this issue to take place.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the directors of the Company are responsible for the release of this announcement.

Notes

Supply@ME Capital PLC and its operating subsidiaries (together the "Group") provide an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/ export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation programme which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This programme will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories.

 

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780, paul.vann@walbrookpr.com 

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317, brian.norris@cicero-group.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFLFSVFTLIVIL
Date   Source Headline
7th Dec 20204:36 pmRNSPrice Monitoring Extension
30th Nov 20207:30 amRNSTrading Update
27th Nov 202011:06 amRNSSecond Price Monitoring Extn
27th Nov 202011:00 amRNSPrice Monitoring Extension
12th Nov 202011:05 amRNSSecond Price Monitoring Extn
12th Nov 202011:00 amRNSPrice Monitoring Extension
3rd Nov 20207:00 amRNSUAE Update: Official launch of the Shari’a project
30th Oct 20207:00 amRNSInventory Funding: Securitisation Issue Update
26th Oct 20207:00 amRNSPrice Monitoring Extension
22nd Oct 202011:05 amRNSSecond Price Monitoring Extn
22nd Oct 202011:00 amRNSPrice Monitoring Extension
22nd Oct 202010:09 amRNSStrategic Agreement to launch in The United States
12th Oct 202011:52 amRNSAppointment of New Auditor
9th Oct 20202:06 pmRNSSecond Price Monitoring Extn
9th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20202:05 pmRNSSecond Price Monitoring Extn
30th Sep 20202:00 pmRNSPrice Monitoring Extension
29th Sep 20209:00 amRNSPrice Monitoring Extension
28th Sep 20207:02 amRNSUpdate on Business Operations
25th Sep 202010:00 amRNSDirector/PDMR Shareholding
25th Sep 20207:00 amRNSStatement regarding Orchestra Group Call Option
24th Sep 202012:20 pmRNSHolding(s) in Company
24th Sep 202012:20 pmRNSDirector/PDMR Shareholding
24th Sep 20209:05 amRNSSecond Price Monitoring Extn
24th Sep 20209:00 amRNSPrice Monitoring Extension
21st Sep 20209:06 amRNSSecond Price Monitoring Extn
21st Sep 20209:00 amRNSPrice Monitoring Extension
21st Sep 20207:00 amRNSEUR 8bn Funding Agreement with Bank acquisition
17th Sep 20207:00 amRNSResponse to erroneous media article
10th Sep 202011:05 amRNSSecond Price Monitoring Extn
10th Sep 202011:00 amRNSPrice Monitoring Extension
10th Sep 20207:00 amRNSInventory Funding and Investor Update
8th Sep 20207:00 amRNSHolding in Company
8th Sep 20207:00 amRNSDirector/PDMR Shareholding
4th Sep 20207:00 amRNSAlliance with leading Italian SME Fintech Platform
28th Aug 20207:00 amRNSHolding in Company
28th Aug 20207:00 amRNSDirector/PDMR Shareholding
21st Aug 20209:05 amRNSSecond Price Monitoring Extn
21st Aug 20209:00 amRNSPrice Monitoring Extension
21st Aug 20207:00 amRNSHolding(s) in Company
21st Aug 20207:00 amRNSDirector/PDMR Shareholding
20th Aug 20209:05 amRNSSecond Price Monitoring Extn
20th Aug 20209:00 amRNSPrice Monitoring Extension
19th Aug 202011:06 amRNSSecond Price Monitoring Extn
19th Aug 202011:00 amRNSPrice Monitoring Extension
19th Aug 20209:05 amRNSSecond Price Monitoring Extn
19th Aug 20209:00 amRNSPrice Monitoring Extension
18th Aug 20209:05 amRNSSecond Price Monitoring Extn
18th Aug 20209:00 amRNSPrice Monitoring Extension
18th Aug 20207:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.